Serum monocyte chemoattractant protein-1 is a biomarker in patients with diabetes and periodontitis

Introduction: The role of serum Monocyte Chemoattractant Protein-1 (MCP-1) as a biomarker of periodontitis is well documented; however, its role in diabetic patients with periodontitis is unknown. Aim : This study was conducted to determine the presence and concentration of serum MCP-1 in diabetic p...

Full description

Bibliographic Details
Main Authors: Preethi Radhakrishnan, Padma Srikanth, Krishna G Seshadri, Ramya Barani, Maitreya Samanta
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2014-01-01
Series:Indian Journal of Endocrinology and Metabolism
Subjects:
Online Access:http://www.ijem.in/article.asp?issn=2230-8210;year=2014;volume=18;issue=4;spage=505;epage=510;aulast=Radhakrishnan
_version_ 1811281555677511680
author Preethi Radhakrishnan
Padma Srikanth
Krishna G Seshadri
Ramya Barani
Maitreya Samanta
author_facet Preethi Radhakrishnan
Padma Srikanth
Krishna G Seshadri
Ramya Barani
Maitreya Samanta
author_sort Preethi Radhakrishnan
collection DOAJ
description Introduction: The role of serum Monocyte Chemoattractant Protein-1 (MCP-1) as a biomarker of periodontitis is well documented; however, its role in diabetic patients with periodontitis is unknown. Aim : This study was conducted to determine the presence and concentration of serum MCP-1 in diabetic patients with and without periodontitis and correlate it glycemic status with periodontitis. Materials and Methods: Adult diabetic patients were enrolled and grouped into group I, II, and III based on their glycemic status and serum MCP-1 estimated by ELISA. Linear regression and correlation tests were performed using R statistical software, Medcalc software to observe correlation between the serum MCP-1 and glycated hemoglobin level among different groups. Results: Serum samples obtained from 37 patients tested positive for MCP-1. Mean serum MCP-1 concentration was highest (482.3 pg/ml) in group III, lowest (149.3 pg/ml) in group I, and intermediate 398.8 pg/ml in group II. Correlation and regression analysis was done between HbA1c and serum MCP-1. A significant positive correlation (P < 0.001) was observed. Serum MCP-1 increased by 37.278 pg/ml for every 1% rise in HbA1c, and the levels were raised in group II and group III than in group I irrespective of their glycemic status. With an HbA1c range of 6.5-6.9% (group II), the serum MCP-1 values cluster around 380-410 pg/ml. Elevated levels of serum MCP-1 (>500 pg/ml) in three subjects corresponded to HbA1c values more than 12.2% (group III). Conclusion: To our knowledge, this is the first study to document serum MCP-1 levels in diabetic patients with periodontitis. Glycemic status influences serum MCP-1, and lack of glycemic control contributes to increased serum MCP-1 levels. Serum MCP-1 may thus serve as a biomarker of inflammation and disease progression in diabetes with periodontitis.
first_indexed 2024-04-13T01:35:42Z
format Article
id doaj.art-c2bcfe30b019489d907c690604e7f6e6
institution Directory Open Access Journal
issn 2230-8210
2230-9500
language English
last_indexed 2024-04-13T01:35:42Z
publishDate 2014-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Endocrinology and Metabolism
spelling doaj.art-c2bcfe30b019489d907c690604e7f6e62022-12-22T03:08:24ZengWolters Kluwer Medknow PublicationsIndian Journal of Endocrinology and Metabolism2230-82102230-95002014-01-0118450551010.4103/2230-8210.137498Serum monocyte chemoattractant protein-1 is a biomarker in patients with diabetes and periodontitisPreethi RadhakrishnanPadma SrikanthKrishna G SeshadriRamya BaraniMaitreya SamantaIntroduction: The role of serum Monocyte Chemoattractant Protein-1 (MCP-1) as a biomarker of periodontitis is well documented; however, its role in diabetic patients with periodontitis is unknown. Aim : This study was conducted to determine the presence and concentration of serum MCP-1 in diabetic patients with and without periodontitis and correlate it glycemic status with periodontitis. Materials and Methods: Adult diabetic patients were enrolled and grouped into group I, II, and III based on their glycemic status and serum MCP-1 estimated by ELISA. Linear regression and correlation tests were performed using R statistical software, Medcalc software to observe correlation between the serum MCP-1 and glycated hemoglobin level among different groups. Results: Serum samples obtained from 37 patients tested positive for MCP-1. Mean serum MCP-1 concentration was highest (482.3 pg/ml) in group III, lowest (149.3 pg/ml) in group I, and intermediate 398.8 pg/ml in group II. Correlation and regression analysis was done between HbA1c and serum MCP-1. A significant positive correlation (P < 0.001) was observed. Serum MCP-1 increased by 37.278 pg/ml for every 1% rise in HbA1c, and the levels were raised in group II and group III than in group I irrespective of their glycemic status. With an HbA1c range of 6.5-6.9% (group II), the serum MCP-1 values cluster around 380-410 pg/ml. Elevated levels of serum MCP-1 (>500 pg/ml) in three subjects corresponded to HbA1c values more than 12.2% (group III). Conclusion: To our knowledge, this is the first study to document serum MCP-1 levels in diabetic patients with periodontitis. Glycemic status influences serum MCP-1, and lack of glycemic control contributes to increased serum MCP-1 levels. Serum MCP-1 may thus serve as a biomarker of inflammation and disease progression in diabetes with periodontitis.http://www.ijem.in/article.asp?issn=2230-8210;year=2014;volume=18;issue=4;spage=505;epage=510;aulast=RadhakrishnanGlycemic controlperiodontitisserum Monocyte Chemoattractant Protein-1
spellingShingle Preethi Radhakrishnan
Padma Srikanth
Krishna G Seshadri
Ramya Barani
Maitreya Samanta
Serum monocyte chemoattractant protein-1 is a biomarker in patients with diabetes and periodontitis
Indian Journal of Endocrinology and Metabolism
Glycemic control
periodontitis
serum Monocyte Chemoattractant Protein-1
title Serum monocyte chemoattractant protein-1 is a biomarker in patients with diabetes and periodontitis
title_full Serum monocyte chemoattractant protein-1 is a biomarker in patients with diabetes and periodontitis
title_fullStr Serum monocyte chemoattractant protein-1 is a biomarker in patients with diabetes and periodontitis
title_full_unstemmed Serum monocyte chemoattractant protein-1 is a biomarker in patients with diabetes and periodontitis
title_short Serum monocyte chemoattractant protein-1 is a biomarker in patients with diabetes and periodontitis
title_sort serum monocyte chemoattractant protein 1 is a biomarker in patients with diabetes and periodontitis
topic Glycemic control
periodontitis
serum Monocyte Chemoattractant Protein-1
url http://www.ijem.in/article.asp?issn=2230-8210;year=2014;volume=18;issue=4;spage=505;epage=510;aulast=Radhakrishnan
work_keys_str_mv AT preethiradhakrishnan serummonocytechemoattractantprotein1isabiomarkerinpatientswithdiabetesandperiodontitis
AT padmasrikanth serummonocytechemoattractantprotein1isabiomarkerinpatientswithdiabetesandperiodontitis
AT krishnagseshadri serummonocytechemoattractantprotein1isabiomarkerinpatientswithdiabetesandperiodontitis
AT ramyabarani serummonocytechemoattractantprotein1isabiomarkerinpatientswithdiabetesandperiodontitis
AT maitreyasamanta serummonocytechemoattractantprotein1isabiomarkerinpatientswithdiabetesandperiodontitis